Evaluation of antiulcerogenic activity of aqueous extract of Brassica oleracea var. capitata (cabbage) on wistar rat gastric ulceration;Avaliação da atividade antiúlcera do extrato aquoso de Brassica oleracea var. capitata (repolho) em úlceras gástricas de ratos Wistar.

Arquivos de Gastroenterologia

Volumn 48, Issue 4, 2011, Pages 276-286

  de carvalho, Camilo Amaro ^a   Fernandes, Kenner Moraes ^a   Matta, Sérgio Luiz Pinto ^a   da Silva, Marcelo Barreto ^b   da Oliveira, Leandro Licursi ^a   Fonseca, Cĺaudio César ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Anti ulcer agents; Brassica; Rats; Stomach ulcer

Indexed keywords

ACETYLSALICYLIC ACID; ANTIULCER AGENT; BRASSICA OLERACEA EXTRACT; OMEPRAZOLE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIULCEROGENIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CABBAGE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; MALE; NONHUMAN; PLANT LEAF; RAT; STOMACH INJURY; STOMACH PROTECTION; STOMACH ULCER; ULCER HEALING; WISTAR RAT;

EID: 83255165384     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032011000400011     Document Type: Article

References (35)

1. Aguwa CN. Incidence of gastric ulcers by indomethacin and piroxicam in rats. Arch Toxicol. 1985;56:212-3.
2. Ajaikumar KB, Asheef M, Babu BH, padikkala J. The inhibition of gastric mucosal injury by Punicagranatum L. (pomegranate) methanolic extract. J Ethnopharmacol. 2005;96:171-6.
3. Alcaraz MJ, Hoult JR. Effects of hypolaetin-8-glucoside and related flavonoids on soybean lipoxygenase and snake venom phospholipase A2. Arch Int pharmacodyn Ther. 1985;278:4-12.
4. a ed. Itaquaquecetuba: Vida plena; 1992. p.292.
5. Bancroft JD, Stevens A. Theory and practice of histological techniques. 4th ed. New York: Churchill Livingstone; 1996.
6. Beck PL, Xavier R, Lu N, Nanda NN, Dinauer M, podolsky DK, Seed B. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology. 2000;119:699-705.
7. Beil W, Birkholz C, Sewing KF. Effects of flavonoids on parietal cell acid secretion, gastric mucosal prostaglandin production and Helicobacter pylori growth. Arzneimittelforschung. 1995;45:697-700.
8. Berenguer B, Alarcon de la Lastra C, Moreno FJ, Martin MJ. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors. Eur J pharmacol. 2002;442:125-35.
9. Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res. 2000;14:581-91.
10. Bronner C, Landry Y., Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions. 1985;16:147-51.
11. Brunton LL, &/x&&namegr type=editor&&name&&sname&Lazo&/sname&&x& &/x&&fname&JS&/fname&&/name&&x&, &/x&&name&&sname&parker&/sname&&x& &/x&&fname&KL&/fname&&/name&&/namegr&, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2007.
12. Carvalho CA, Silva MB, Oliveira TG, Lima JM, Rosa MB. Spectrometric study at different phenologic stages of the cabbage (Brassica oleraceae var. capitata). Rev Bras Farmacogn. 2008;18:249-57.
13. Cheney G. Vitamin U therapy of peptic ulcer. Calif Med. 1952;77:248-52.
14. Conselho Federal de Medicina Veterinaria. Resolugao n. 714 de 20 de junho de 2002. Dispoe sobre procedimento de eutanasia em animais e da outras providencias. Diario Oficial da Uniao, Brasilia, DF., 21 de junho de 2002.
15. a ed. Rio de Janeiro: Guanabara Koogan; 1993.
16. Gonul B, Akbulut KG, Ozer C, Yetkin G, Celebi N. The role of transforming growth factor alpha formulation on aspirin-induced ulcer healing and oxidant stress in the gastric mucosa. Surg Today. 2004;34:1035-40.
17. Gonzalez FG, Di Stasi LC. Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice. Phytomedicine. 2002;9:125-34.
18. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002;96:67-202.
19. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology. 2000;119:521-35.
20. Institute of Laboratory Animal Resources. Commission on Life Sciences. National Research Council. Manual sobre cuidados e usos de animais de laboratorio. Goiania: AAALAC e COBEA; 2003.
21. Jones NL, Day AS, Sherman PM. Determinants of disease outcome following Helicobacter pylori infection in children. Can J Gastroenterol. 1999;13:613-17.
22. Jones NL, Sherman PM., Helicobacter pylori-epithelial cell interactions: from adhesion to apoptosis. Can J Gastroenterol. 1999;13:563-6.
23. Jones RH, Tait CL. Gastrointestinal side-effects of NSAIDs in the community. Br J Clin Pract. 1995;49:67-70.
24. Lachman L, Lieberman HA, Kaning JL. Teoria e pratica na industria farmaceutica. 5a ed. Lisboa: Fundagao Calouste Gulbenkian; 2001.
25. Popovic M, Janicijevic-Hudomal S, Kaurinovic B, Rasic J, Trivic S. Antioxidant effects of some drugs on ethanol-induced ulcers. Molecules. 2009;14:816-26.
26. Scheiman J, Herlitz J, Devereaux P, Naucler E, Erik L. Low-dose acetylsalicylic acid-associated peptic ulcers and dyspeptic symptoms are reduced by esomeprazole 20 mg and 40 mg once daily. Am Coll Cardiol. 2010;55.
27. Siegel S, Castellan JRNJ. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill; 1988. 399p.
28. Silva Jr AA, Miura L, Yokoyama S. Repolho: novas cultivares de verao. Agrop Catarinense. 1988;1(3):47-9.
29. Silva Jr AA. Repolho: fitologia, fitotecnia, tecnologia alimentar e mercadologica. Florianopolis: EMPASC; 1989.
30. Silva MB, Silva CA, Malaquias LCC, Sarandy MM, Freire MCM, Antunes, FR, Costa AVS. Comparative effect of a phytotherapeutic product from Brassica ssp as cicatrizing. Rev Bras Pl Med. 2006;8:136-8.
31. Tarnawski A, Douglass TG, Stachura J, Krause WJ. Quality of gastric ulcer healing: histological and ultrastructural assessment. Aliment Pharmacol Ther. 1991;5:79-90.
32. Villegas I, Martin MJ, La Casa C, Motilva V, Alarcon de la Lastra C. Effects of meloxicam on oxygen radical generation in rat gastric mucosa. Inflamm Res. 2000;49:361-6.
33. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277:922-3.
34. Wright V. Historical overview of non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1995;34:2-4.
35. Yunes RA, Pedrosa RC, Cechinel Filho V. Pharmaceutics and phytotherapics: the need for development of the industry of phytopharmaceutics and phytotherapics in Brazil. Quim Nova. 2001;24:147-52.